Cargando…
Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease
PURPOSE OF REVIEW: We review the growing clinical evidence that metabolic acidosis mediates chronic kidney disease (CKD) progression and that treatment to increase the associated low serum bicarbonate (HCO(3)) in CKD is disease-modifying. RECENT FINDINGS: Seven prospective studies of patients with w...
Autores principales: | Goraya, Nimrit, Wesson, Donald E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467553/ https://www.ncbi.nlm.nih.gov/pubmed/30681417 http://dx.doi.org/10.1097/MNH.0000000000000491 |
Ejemplares similares
-
Does erythropoietin slow progression of chronic kidney disease?
por: Nasri, Hamid, et al.
Publicado: (2013) -
Kidney Response to the Spectrum of Diet-Induced Acid Stress
por: Goraya, Nimrit, et al.
Publicado: (2018) -
Administration of antioxidants in chronic kidney disease
por: Tamadon, Mohamad Reza, et al.
Publicado: (2015) -
Acute kidney injury; the focus of world kidney day in 2013
por: Ardalan, Mohammad-Reza, et al.
Publicado: (2013) -
Radiation-induced kidney injury
por: Baradaran-Ghahfarokhi, Milad
Publicado: (2012)